Interpretation of Guidelines for the Investigation of Chronic Diarrhoea in Adults: British Society of Gastroenterology in 2018

doi:10.12114/j.issn.1007-9572.2020.00.432

Abstract

Abstract: The 3rd edition of the Guidelines for the Investigation of Chronic Diarrhoea in Adults was published online in Gut by the British Society of Gastroenterology in April 2018，which updated the 2nd edition of the guidelines in 2003. This new edition of the guidelines describes the clinical assessment process，tumor and inflammation assessment，malabsorption test，and the management of common causes，structural/surgical causes and rare causes in chronic diarrhoea. Based on the updated contents of this guideline，this paper discusses the common misunderstandings in the diagnosis and treatment of adult chronic diarrhoea，including incomplete collection of medical history and difficulty in etiological diagnosis；failure to consider bile acid diarrhoea as a common cause of chronic diarrhoea；delayed diagnosis and treatment of celiac disease；failure to take biopsy in colonoscopy；missed diagnosis of colorectal cancer in young patients with chronic diarrhoea；non identification of overflow diarrhoea in the elderly；lack of awareness of the clinical significance of intestinal bacterial overgrowth detection method，and the corresponding countermeasures are proposed.

Key words: Diarrhoea, Adults, Guideline, Interpretation

摘要： 2018年4月英国胃肠病学会（BSG）在Gut上发表了第3版《成人慢性腹泻的调查指南》，对2003年第2版指南进行了更新，新版指南对慢性腹泻的临床评估流程、肿瘤和炎症评估、吸收不良的检测，以及常见病因、结构性/手术病因、少见病因的管理等方面进行阐述。本文结合此指南更新内容探讨成人慢性腹泻诊疗中的常见误区，包括：病史采集不全面，病因诊断困难；未把胆汁酸性腹泻作为慢性腹泻的常见病因考虑；乳糜泻诊治延迟；结肠镜检查不取活检；年轻慢性腹泻患者中漏诊结直肠癌；对老年人溢出性腹泻不识别；对小肠细菌过度生长检测方法的临床意义认知不足，针对这些误区给出相应的应对策略。

关键词: 腹泻, 成年人, 指南, 解读

ZHU Xinying,ZHAO Dongqiang. Interpretation of Guidelines for the Investigation of Chronic Diarrhoea in Adults: British Society of Gastroenterology in 2018　[J]. Chinese General Practice, 2021, 24(7): 780-783. DOI: 10.12114/j.issn.1007-9572.2020.00.432.
朱新影,赵东强. 2018年英国胃肠病学会《成人慢性腹泻的调查指南》解读[J]. 中国全科医学, 2021, 24(7): 780-783. DOI: 10.12114/j.issn.1007-9572.2020.00.432.

References

［1］FAGUNDES-NETO U．Persistent diarrhea：still a serious public health problem in developing countries［J］．Curr Gastroenterol Rep，2013，15（9）：345．DOI：10.1007/s11894-013-0345-1.
［2］ARASARADNAM R P，BROWN S，FORBES A，et al．Guidelines for the investigation of chronic diarrhoea in adults：British Society of Gastroenterology，3rd edition［J］．Gut，2018，67（8）：1380-1399．DOI：10.1136/gutjnl-2017-315909.
［3］张莉娟，江勇，刘炳华，等．成年人慢性腹泻病因的研究进展［J］．中国全科医学，2019，22（22）：2760-2765．DOI：10.12114/j.issn.1007-9572.2019.00.378.
ZHANG L J，JIANG Y，LIU B H，et al．Advances in the etiology of chronic diarrhea in adults ［J］．Chinese General Practice，2019，22（22）：2760-2765．DOI：10.12114/j.issn.1007-9572.2019.00.378.
［4］VALENTIN N，CAMILLERI M，ALTAYAR O，et al．Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea：a systematic review and meta-analysis ［J］．Gut，2016，65（12）：1951-1959．DOI：10.1136/gutjnl-2015-309889.
［5］WEDLAKE L，A'HERN R，RUSSELL D，et al．Systematic review：the prevalence of idiopathic bile acid malabsorption（I-BAM） as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome（IBS）［J］．Aliment Pharmacol Ther，2009，30（7）：707-717．
［6］BANNAGA A，KELMAN L，O'CONNOR M，et al．How bad is bile acid diarrhoea：an online survey of patient-reported symptoms and outcomes［J］．BMJ Open Gastroenterol，2017，4（1）：e000116．DOI：10.1136/bmjgast-2016-000116.
［7］TURNER J M，PATTNI S S，APPLEBY R N，et al．A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhea［J］．Frontline Gastroenterol，2017，8（4）：279-283．DOI：10.1136/flgastro-2017-100826.
［8］FERNANDES D C R，POON D，WHITE L L，et al．What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?［J］．Frontline Gastroenterol，2019，10（1）：72-76.DOI：10.1136/flgastro-2018-101011.
［9］ROSS S，D'MELLO M，ANAND S S，et al．Effect of bile acid sequestrants on the risk of cardiovascular events：a mendelian randomization analysis［J］．Circ Cardiovasc Genet，2015，8（4）：618-627．DOI：10.1161/CIRCGENETICS.114.000952.
［10］SAUTER G H，MüNZING W，VON RITTER C，et al．Bile acid malabsorption as a cause of chronic diarrhea：diagnostic value of 7-alpha-hydroxy-4-cholesten-3-one in serum ［J］．Dig Dis Sci，1999，44（1）：14-19．DOI：10.1023/a:1026681512303.
［11］CAMILLERI M．Advances in understanding of bile acid diarrhea［J］．Expert Rev Gastroenterol Hepatol，2014，8（1）：49-61．DOI：10.1586/17474124.2014.851599.
［12］CAMILLERI M，BUSCIGLIO I，ACOSTA A，et al．Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea［J］．Am J Gastroenterol，2014，109（10）：1621-1630．DOI：10.1038/ajg.2014.215.
［13］VIJAYVARGIYA P，CAMILLERI M，CARLSON P，et al．Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhea［J］．Aliment Pharmacol Ther，2017，46（6）：581-588．DOI：10.1111/apt.14214.
［14］VIJAYVARGIYA P，CAMILLERI M，CHEDID V，et al．Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea ［J］．Clin Gastroenterol Hepatol，2019，17（5）：922-929．DOI：10.1016/j.cgh.2018.05.050．
［15］OREKOYA O，MCLAUGHLIN J，LEITAO E，et al．Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy［J］．Clin Med，2015，15（3）：252-257．DOI：10.7861/clinmedicine.15-3-252．
［16］TORTORA R，ZINGONE F，RISPO A，et al．Coeliac disease in the elderly in a tertiary centre［J］．Scand J Gastroenterol，2016，51（10）：1179-1183．DOI：10.1080/00365521.2016.1186222.
［17］FUCHS V，KURPPA K，HUHTALA H，et al．Factors associated with long diagnostic delay in celiac disease［J］．Scand J Gastroenterol，2014，49（11）：1304-1310．DOI：10.3109/00365521.2014.923502.
［18］AL-TOMA A，VOLTA U，AURICCHIO R，et al．European Society for the Study of Coeliac Disease（ESsCD） guideline for coeliac disease and other gluten-related disorders［J］．United European Gastroenterol，2019，7（5）：583-613．
［19］GUAGNOZZI D，ARIAS á，LUCENDO A J．Systematic review with meta-analysis：diagnostic overlap of microscopic colitis and functional bowel disorders［J］．Aliment Pharmacol Ther，2016，43（8）：851-862．DOI：10.1111/apt.13573.
［20］NGUYEN G C，SMALLEY W E，VEGE S S，et al．American Gastroenterological Association Institute guideline on the medical management of microscopic colitis［J］．Gastroenterology，2016，150（1）：242-246．DOI：10.1053/j.gastro.2015.11.008.
［21］PARDI D S，TREMAINE W J，CARRASCO-LABRA A．American Gastroenterological Association Institute technical review on the medical management of microscopic colitis［J］．Gastroenterology，2016，150（1）：247-274．DOI：10.1053/j.gastro.2015.11.006.
［22］LANGNER C，AUST D，ENSARI A，et al．Histology of microscopic colitis-review with a practical approach for pathologists［J］．Histopathology，2015，66（5）：613-626．
［23］PATEL S G，AHNEN D J．Colorectal cancer in the young［J］．Curr Gastroenterol Rep，2018，20（4）：15．DOI：10.1007/s11894-018-0618-9.
［24］RHODES J M，MIDDLETON P，JEWELL D P．The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth［J］．Scand J Gastroenterol，1979，14（3）：333-336．DOI：10.3109/00365527909179892.
［25］CHOUNG R S，RUFF K C，MALHOTRA A，et al．Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture［J］．Aliment Pharmacol Ther，2011，33（9）：1059-1067．DOI：10.1111/j.1365-2036.2011.04625.x.
［26］ERDOGAN A，RAO S S，GULLEY D，et al．Small intestinal bacterial overgrowth：duodenal aspiration vs. glucose breath test［J］．Neurogastroenterol Motil，2015，27（4）：481-489．DOI：10.1111/nmo.12516.

[1]	BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746.
[2]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[3]	CUI Yiyuan, YAN Yijing, WANG Ying, MENG Xiangju, ZHANG Qinglin, LIU Lixing, LI Sicong, FENG Li, The Working Group for the Clinical Practice Guideline for the Cancer-related Fatigue with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Cancer-related Fatigue [J]. Chinese General Practice, 2025, 28(27): 3345-3358.
[4]	CUI Yuyang, CHENG Guirong, ZENG Yan, HUANG Zhaolan, TAN Wei. Association between Marital Status, Social Support and Lifestyle with Cognitive Impairment among Community-dwelling Older Adults: Based on the Baseline Survey of Hubei Memory and Aging Cohort Study [J]. Chinese General Practice, 2025, 28(26): 3240-3247.
[5]	ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228.
[6]	YANG Jiang, LI Jiansheng, CHEN Yaolong, LIU Huiguo, WANG Jianxin, YU Jiajie, LI Huiru, XIAO Qionghua, XIE Yang, LI Suyun, WANG Minghang. Guideline on Treating Adult Community-acquired Pneumonia with Chinese Patent Medicines (2025 Edition) [J]. Chinese General Practice, 2025, 28(20): 2464-2480.
[7]	CAO Qinhan, ZHUO Xiao, XIA Yuhan, CHE Yangxi, CHEN Min. Interpretation of Updated NCCN Clinical Guidelines for Rectal Cancer (2024.V1/V2) [J]. Chinese General Practice, 2025, 28(17): 2070-2074.
[8]	XIA Yuhan, ZHUO Xiao, CAO Qinhan, LIAO Xingyu, LUO Guoliang, TANG Taichun, CHEN Min. Interpretation of the Updated NCCN Clinical Practice Guidelines for Colon Cancer (2024.V4) [J]. Chinese General Practice, 2025, 28(14): 1689-1693.
[9]	MA Guifen, ZHANG Qian, SUN Jing. Interpretation of the Key Updates in the Latest Version of 2024 NCCN Clinical Practice Guidelines for Gastric Cancer [J]. Chinese General Practice, 2025, 28(14): 1681-1688.
[10]	Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association, Sleep Medicine Group, China Neurologist Association. Chinese Guideline for Diagnosis and Treatment of Co-morbid Insomnia and Obstructive Sleep Apnea (2024) [J]. Chinese General Practice, 2025, 28(11): 1289-1303.
[11]	ZHOU Yiheng, LYU Yao, YANG Ziyu, YANG Rong, LIU Lidi, ZHANG Peng, DAI Hua, ZENG Rui, WAN Zhi, JIA Yu, LIU Changming, LEI Yi, LIAO Xiaoyang. Interpretation of the Consensus Statement of the British and Irish Hypertension Societies on Adult Hypertension Referral Pathway and Therapeutic Management [J]. Chinese General Practice, 2025, 28(10): 1173-1178.
[12]	YANG Le, LI Zhenhao, YAO Dianrui, YANG Yang, SUN Yufang, HE Ying. Cognitive Function of Older Adults Relocated for Poverty Alleviation and Its Influencing Factors [J]. Chinese General Practice, 2025, 28(08): 939-947.
[13]	YAO Dingye, LUO Guiping, SUN Junsheng, REN Jingjing. Diagnosis and Treatment of Halitosis: a General Practice Perspective [J]. Chinese General Practice, 2025, 28(07): 900-904.
[14]	MA Hongyang, YUE Anna, SUN Kangyun. Familial Hypercholesterolemia: Diagnostic Differences between Domestic and Foreign Guidelines [J]. Chinese General Practice, 2025, 28(06): 655-665.
[15]	FANG Xiang, SONG Haiqi, LIAO Xiaoyang, LIU Lidi, ZHANG Peng, JIA Yu, YANG Ziyu, YANG Rong, LIU Ruhui. Recommendations for the Management of Hypertensive Disorders of Pregnancy in China: Based on the A Summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand Hypertension in Pregnancy Guideline [J]. Chinese General Practice, 2025, 28(06): 649-654.